logo

Human trial for COVID-19 vaccine launched by Johnson & Johnson

Johnson & Johnson has confirmed that a human trial for a COVID-19 vaccine has begun in the United States and Belgium after positive results were seen in its study with monkeys.


Tue Aug 04 2020 | 11:00:29 GMT+0000 (Coordinated Universal Time)


Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent. Sign up here.